Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNMT1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |